AbstractThis article explores the ethical, religious, and process complexities surrounding the use of animal-derived products in medicine, using the case of a 19-year-old Muslim patient with homozygous familial hypercholesterolemia, receiving lifesaving LDL apheresis with porcine-derived heparin. Despite the critical role of LDL apheresis to manage her high cholesterol levels over the past year, the charge nurse has recently raised concerns owing to the porcine origin of the anticoagulant used in her treatment, recognizing that this may conflict with her religious beliefs. This case raises critical questions about the disclosure of ethically sensitive information during the consent process. Should providers disclose the origin of such products, even when they are essential and no alternatives exist? Balancing respect for patient autonomy with concerns about moral distress and potential treatment refusal highlights the challenges in culturally informed care. The article examines the broader implications of these dilemmas, emphasizing the necessity of cultural humility in healthcare. While Islamic bioethics and other faith traditions may permit the use of prohibited substances in lifesaving situations, interpretations vary widely. Providers must engage patients in open, respectful dialogues to understand their individual values, avoiding harmful generalizations.
Patten et al. (2026) studied this question.